Amlan Ray's practice is concentrated on patent counseling and litigation with an emphasis on pharmaceutical patent matters arising under the Hatch-Waxman Act.
Amlan represents prominent generic pharmaceutical companies on a wide range of matters such as developing strategies for paragraph IV challenges to Orange Book patents, analyzing patent portfolio for potential product acquisition and evaluating patents for a diverse range of technical areas such as molecule challenge, chemical process analysis and medicinal chemistry, formulation and polymorph issues.
He has extensive experience in client counseling and drafting legal opinions on issues regarding patentability, infringement analysis, due diligence and freedom-to-operate. While he was a Graduate Assistant at Rutgers University, he conducted research in the field of homogeneous catalysis for small molecule functionalization and polymer modification.
He is well-versed in various analytical techniques and has years of research experience in the field of organic/inorganic synthesis, polymers, bio-ceramics, x-ray crystallography and co-authored a number of scientific articles.
- The Best Lawyers in America: Ones to Watch - Litigation-Intellectual Property (2021-2022)
- Best Lawyers in America 2022 Recognizes 22 Windels Marx Lawyers, 9 Ones to Watch - Aug 19, 2021
- Best Lawyers in America 2021 Recognizes 22 Windels Marx Lawyers, 9 Ones to Watch, 4 Lawyers of the Year - Aug 20, 2020
- Windels Marx Significantly Expands its NJ Practice with the Arrival of a Prominent Intellectual Property - Hatch-Waxman Act Practice Group - Apr 15, 2019
- J.D., Seton Hall University School of Law, 2015
- Ph.D., Rutgers University, 2007
- M. Tech, Indian Institute of Technology, Bombay, India, 2000
- M.S., Indian Institute of Technology, Kharagpur, India, 1998
- New Jersey
- New York